Health claim

“A prostate‑specific antigen (PSA) blood test is used to screen for prostate cancer but can be elevated in benign prostatic hyperplasia.”

Claim checked — strong evidenceHigh riskmedications

Evidence Summary

Multiple well-designed studies consistently support this claim.

PSA testing is used for prostate cancer screening, but PSA levels can also rise in benign prostatic hyperplasia, making the statement accurate.

Extracted from

Enlarged Prostate vs Prostate Cancer: What's the Difference?

The Prostate Clinic

The video explains the clinical distinctions between an enlarged prostate (benign prostatic hyperplasia) and prostate cancer, focusing on symptoms, diagnostic methods, and typical treatment pathways.

Watch breakdown →

Follow Prostate Health

Get an email when new prostate health claims are evidence-checked — or when a verdict changes.

Free newsletter

Get the weekly evidence digest

5 claims reviewed each Friday. No hype.

Unsubscribe any time. No spam.

A prostate‑specific antigen (PSA) blood test is used to screen for prostate cancer but can be elevated in benign prostatic hyperplasia. — Evidence Review — MenHealth Digest